Lipid-Lowering Drugs
- 1 March 1987
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 33 (3), 259-279
- https://doi.org/10.2165/00003495-198733030-00003
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Pediatric Primary Prevention of AtherosclerosisNew England Journal of Medicine, 1986
- Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domainCell, 1985
- Reduction of Plasma Lipids, Lipoproteins, and Apoproteins by Dietary Fish Oils in Patients with HypertriglyceridemiaNew England Journal of Medicine, 1985
- Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacin.Circulation, 1984
- Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.Circulation, 1984
- Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug RegimenNew England Journal of Medicine, 1981
- Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein CatabolismNew England Journal of Medicine, 1980
- Treatment of Hypercholesterolemia with Neomycin — A Time for ReappraisalNew England Journal of Medicine, 1979
- Clinical Pharmacokinetics of Hypolipidaemic DrugsClinical Pharmacokinetics, 1978
- Metabolic relationships among the plasma lipoproteinsJournal of Clinical Investigation, 1972